Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity. J of Skin [Internet]. 2024 Nov. 18 [cited 2026 Apr. 17];8(6):s497. Available from: https://skin.dermsquared.com/skin/article/view/3068